0000914121-13-000351.txt : 20130528 0000914121-13-000351.hdr.sgml : 20130527 20130528161904 ACCESSION NUMBER: 0000914121-13-000351 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130522 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20130528 DATE AS OF CHANGE: 20130528 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ANGIODYNAMICS INC CENTRAL INDEX KEY: 0001275187 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 113146460 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-50761 FILM NUMBER: 13875329 BUSINESS ADDRESS: STREET 1: 14 PLAZA DRIVE CITY: LATHAM STATE: NY ZIP: 12110 BUSINESS PHONE: 5187981215 MAIL ADDRESS: STREET 1: 14 PLAZA DRIVE CITY: LATHAM STATE: NY ZIP: 12110 8-K 1 an27900146-8k.htm CURRENT REPORT an27900146-8k.htm
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_______________

FORM 8-K
________________

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
________________
 
Date of Report (Date of earliest event reported):  May 22, 2013
________________
 
AngioDynamics, Inc.
(Exact Name of Registrant as Specified in Charter)
 
_________________

Delaware
000-50761
11-3146460
     
(State or Other Jurisdiction
of Incorporation)
(Commission File
Number)
(IRS Employer
Identification No.)

 
 14 Plaza Drive, Latham, New York                          12110
 
(Address of Principal Executive Offices)                 (Zip Code)
 
 
(518) 795-1400
 
(Registrant’s telephone number, including area code)
 
________________

 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
 
 
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))
 

 
 
 

Item 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
On May 22, 2013, the employment of Alan Panzer, Senior Vice President and General Manager—U.S. Sales of AngioDynamics, Inc. (the “Company”), with the Company was terminated, without cause, effective July 31, 2013.  Pursuant to the terms of a Separation Agreement and General Release, Mr. Panzer will receive continuation of his current base salary and benefits from August 1, 2013 through February 28, 2014 in accordance with the Company’s customary payroll practices.
 


 
 
 


SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
 
ANGIODYNAMICS, INC.
(Registrant)
  
       
       
Date:  May 28, 2013
By:
/s/ Stephen A. Trowbridge  
    Stephen A. Trowbridge   
    Vice President and General Counsel